Screening of local medicinal plant extracts against multi drugs resistance bacteria

2016 ◽  
Vol 5 (10) ◽  
pp. 4986
Author(s):  
Muhammad Nadeem* ◽  
Sayed Abdullah

Multi Drugs Resistance (MDR) bacteria are mostly resistant to most of antibiotics, this leads to several severe infections and diseases. Thus the desire of new antibiotic sources are required which direct to the screening of new medicinal plants and use against MDR pathogenic bacteria. In our study, the antibacterial activity of three different plant extracts are utilized against pathogenic bacteria in-vitro to treat the infection and disease cause by pathogenic bacteria. The extracts were isolated from Mallotus philippensis, Silybum marianum and Stachys parviflora Benth in four different solvents extracts and were tested against eight pathogenic MDR bacterial strains (Brucella abortus, Escherichia coli, Enterobacter sakazakii, Proteus vulgaris, Klebsiella pneumoniae, Providencia stuartii, Pseudomonas aeruginosa (gram negative) and Staphylococcus aureus (gram positive) through well diffusion and disc diffusion. It was found that the extracts of selected plants showed maximum activity against all bacterial strains. The recorded zones of inhibition were 8.0-26.33mm for methanolic, 6.0-17.66mm for chloroform extracts and 8.01-2.33mm for ethyl acetate extracts.  So, it is cleared from the results that the tested plant extracts have great potential as antibacterial compounds against bacteria. However, further research is required to isolate and identify the active ingredients are vital for further pharmacological evaluation. Also screening of these plants for Anticancer and Anti-diabetic activity will be significant. 

Author(s):  
Kathryn Kelly ◽  
Hannah McColl ◽  
Leandra Hess ◽  
Robert Charvat

The normal intestinal microflora plays pivotal roles in aiding with digestion, stimulating the immune system, and providing protection from enteric pathogens. Despite the importance of these organisms, they are often an innocent bystander, caught in the crossfire during antibiotic treatments intended to target and eliminate invading infectious agents. The collateral damage of antibiotic therapy is a reduction in the population of beneficial bacteria as well as an increased risk for more severe infections, including Clostridium difficile. Additionally, the unpleasant condition termed antibiotic-associated diarrhea is an unfortunate consequence of such treatments. In an attempt to alleviate the intestinal distress, individuals are turning to probiotic supplements, which consist of non-pathogenic bacteria purported to provide various health benefits, such as digestive regularity, prevention of disease, and replenishment of the natural microbiota of the human intestinal tract. However, if the bacterial strains present in the physician-recommended probiotic supplements are overly sensitive to antibiotics, then they would fail to reestablish the intestinal microflora during the course of treatment. The purpose of this project was to test the hypothesis that bacterial strains contained within probiotics are resistant to a variety of common antibiotics. Antibiotic susceptibility was assessed for several over-the-counter probiotic supplements via the Kirby-Bauer Disk Diffusion method on medium specific for lactobacilli propagation. After measuring the zones of inhibition, the probiotics were surprisingly sensitive to two-thirds of the antibiotics tested, with the observed growth inhibition greatly exceeding predetermined standards for susceptibility. These results suggest that concomitantly taking probiotic supplements during a course of antibiotics is likely futile for replenishing the intestinal microbiota. We intend to expand the study to include additional antibiotics and supplements of varying formulations in an attempt to gain insight into which strains may exhibit the least sensitivity and be the most effective for recolonization of the gastrointestinal tract.


2008 ◽  
Vol 3 (7) ◽  
pp. 1934578X0800300 ◽  
Author(s):  
Maximilienne Nyegue ◽  
Paul-Henri Amvam-Zollo ◽  
François-Xavier Etoa ◽  
Huguette Agnaniet ◽  
Chantal Menut

The chemical composition and in vitro bioactivities of essential oils obtained by hydrodistillation of barks of Enantia chlorantha and Polyalthia suaveolens, two Annonaceae from Cameroon were investigated. Chemical analyses by GC and GC-MS showed that for both plants sesquiterpenes are predominant, the main constituents being 1,5-epoxysalvial-4(14)-ene (12.8%), caryophyllene oxide (13.4%), humulene epoxide II (8.1%) and spathulenol (7.0%), for E. chlorantha; β-caryophyllene (16.0%), germacrene D (8.5%), e pi-α-cadinol (8.3%), caryophyllene oxide (7.3%), salvia-4(14)-en-1-one (7.3%) and 5-cadinene (6.0%) for P. suaveolens. Evaluation of the antiradical scavenging activity by the 1,1-diphenyl-2-picryhydrazyl (DPPH) method indicated that the P. suaveolens essential oil was more active (SC50= 0.71 g/L) than that from E. chlorantha (8.0 g/L). In both cases, the essential oils were less efficient than BHT, taken as a reference (8.8 10-3g/L). In vitro microbiological screening revealed that E. chlorantha essential oil presents a significant activity against the three bacterial strains, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus (with a maximum activity > 90% at 2 mg/mL) and six fungal strains, Candida albicans, Microsporum canis, Trychophyton rubrum, Fusarium moniliforme, Aspergillus flavus and Aspergillus niger (with a maximum activity > 75% at 2 mg/mL). The volatile extract of P. suaveolens is globally less efficient, as it does not inhibit the growth of either S. aureus or A. flavus.


2020 ◽  
Vol 11 ◽  
pp. 37-43
Author(s):  
Prof. Teodora P. Popova ◽  
Toshka Petrova ◽  
Ignat Ignatov ◽  
Stoil Karadzhov

The antimicrobial action of the dietary supplement Oxidal® was tested using the classic Bauer and Kirby agar-gel diffusion method. Clinical and reference strains of Staphylococcus aureus and Escherichia coli were used in the studies. The tested dietary supplement showed a well-pronounced inhibitory effect against the microbial strains commensurable with that of the broad-spectrum chemotherapeutic agent Enrofloxacin and showed even higher activity than the broad spectrum antibiotic Thiamphenicol. The proven inhibitory effect of the tested dietary supplement against the examined pathogenic bacteria is in accordance with the established clinical effectiveness standards for antimicrobial agents.


1970 ◽  
Vol 1 (4) ◽  
pp. 82-88 ◽  
Author(s):  
MJ Foysal ◽  
MM Rahman ◽  
M Alam

Studies were conducted to identify Pseudomonas fluorescens isolates from a collection of bacteria isolated from bacterial haemorrhagic septicaemia infected carp and catfish, evaluate their antibiotic sensitivity pattern and screen the antibacterial activity of some medicinal plant extracts against the isolates.. A total of 10 isolates were identified as P. fluorescens by morphological, physiological and biochemical tests. In vitro antibiotic sensitivity test of the P. fluorescens isolates were conducted by disc diffusion method for seven antibiotics where, all of the isolates were found to be sensitive only against streptomycin and gentamycin but, most of the isolates (80%) were found resistant to chloramphenicol (C). Moreover, eighty percent of the isolates showed resistance to multiple antibiotics. A total of 118 plant extracts were screened for their antibacterial activity against the P. fluorescens isolates where the isolates exhibited sensitivity to 30 samples. Leaf extracts of Tamarindus indicus, Terminalia chebula, Citrus aurantifolia, Eugenia caryophyllata and Spondias pinnata were found to inhibit the growth of all of the P. fluorescens isolates. DOI: http://dx.doi.org/10.3329/ijns.v1i4.9733 IJNS 2011 1(4): 82-88


2005 ◽  
Vol 77 (1) ◽  
pp. 41-51 ◽  
Author(s):  
A. Gurib-Fakim ◽  
H. Subratty ◽  
F. Narod ◽  
J. Govinden-Soulange ◽  
F. Mahomoodally

The Mauritian population has a long tradition in the use of ethno-medicine, and the practice is still strong, especially in the treatment of minor ailments. Such interest stems from an existing culture, and many “tisanes” are still prepared from plant materials and sold in several markets around the island.This paper will focus on the various chemical/biological screening techniques currently being used to evaluate the biological properties of medicinal plant extracts. Particular emphasis will be put on extraction and various screening for biological/pharmacological properties. Due consideration will be given to the pharmacological approaches that utilize different animal models for the in vitro and in vivo screening of medicinal plant extracts.


2018 ◽  
Vol 2018 ◽  
pp. 1-8 ◽  
Author(s):  
Agata Cieślik-Bielecka ◽  
Tadeusz Bold ◽  
Grzegorz Ziółkowski ◽  
Marcin Pierchała ◽  
Aleksandra Królikowska ◽  
...  

The aim of the study was to investigate the leukocyte- and platelet-rich plasma (L-PRP) antimicrobial activity. The studied sample comprised 20 healthy males. The L-PRP gel, liquid L-PRP, and thrombin samples were testedin vitrofor their antibacterial properties against selected bacterial strains using the Kirby-Bauer disc diffusion method. Two types of thrombin were used (autologous and bovine). Zones of inhibition produced by L-PRP ranged between 6 and 18 mm in diameter. L-PRP inhibited the growth ofStaphylococcus aureus(MRSA and MSSA strains) and was also active againstEnterococcus faecalisandPseudomonas aeruginosa. There was no activity againstEscherichia coliandKlebsiella pneumoniae. The statistically significant increase of L-PRP antimicrobial effect was noted with the use of major volume of thrombin as an activator. Additionally, in groups where a bovine thrombin mixture was added to L-PRP the zones of inhibition concerning MRSA,Enterococcus faecalis, andPseudomonas aeruginosawere larger than in the groups with autologous thrombin. Based on the conducted studies, it can be determined that L-PRP can evokein vitroantimicrobial effects and might be used to treat selected infections in the clinical field. The major volume of thrombin as an activator increases the strength of the L-PRP antimicrobial effect.


2017 ◽  
Vol 55 (11) ◽  
pp. 3167-3174 ◽  
Author(s):  
Xavier Argemi ◽  
Yves Hansmann ◽  
Philippe Riegel ◽  
Gilles Prévost

ABSTRACTThe implication of coagulase-negative staphylococci in human diseases is a major issue, particularly in hospital settings wherein these species often act as opportunistic pathogens. In addition, some coagulase-negative staphylococci such asS. lugdunensishave emerged as pathogenic bacteria, implicated in severe infections, particularly, osteoarticular infections, foreign-body-associated infections, bacteremia, and endocarditis.In vitrostudies have shown the presence of several putative virulence factors such as adhesion factors, biofilm production, and proteolytic factors that might explain clinical manifestations. Taken together, the clinical and microbiological data might change the way clinicians and microbiologists look atS. lugdunensisin clinical samples.


Sign in / Sign up

Export Citation Format

Share Document